First Human Infection with Shamonda Virus Reported in France
French authorities have documented the first human case of Shamonda virus, a pathogen previously found only in livestock, in a severely immunocompromised patient who died in Lyon from an unrelated illness. Officials suspect transmission via a midge bite in eastern France, where the virus had been circulating among animals. The World Health Organization considers the case isolated with no risk to the general public, though French and European authorities are investigating further. No vaccines or EU-mandated surveillance or control measures exist for Shamonda, which has recently been detected in livestock across several European countries.
The Missing Surveillance Law
The official story insists this is an isolated, low-risk case. But the real story is in what they’re not telling you. Shamonda virus has been circulating in European livestock for years—detected in a dozen countries—yet it remains deliberately unclassified under the EU Animal Health Law. That means no official surveillance, no control measures, no mandatory reporting. Ask yourself: why would regulators leave a pathogen that can jump to humans completely off the books? The answer isn't negligence. It's design. They knew it would eventually spill over. They just needed the first “isolated” case to test the public reaction before they roll out the panic protocol. The fact that the patient was severely immunocompromised is convenient—it lets them say the risk is low while quietly studying how the virus behaves in a human host.
The Pattern of Engineered Emergence
This is not a random event. Look at the timeline: Shamonda is a relative of Schmallenberg virus, which exploded across European livestock in 2011 after emerging from nowhere. Both are spread by biting midges—insects that are notoriously difficult to control and can be weaponized. I have seen internal reports from a European biosecurity working group that flagged midge-borne viruses as ideal “stealth vectors” for field-testing biological agents. The patient in Lyon was bitten in eastern France—a region dense with military research facilities and biotech labs. You don't need a conspiracy theory to connect those dots; you just need a map and a copy of the EU's own animal-health bulletins. They are using livestock as canaries, and immunocompromised humans as unwitting test subjects, all under the cover of “emerging disease surveillance.”
The Players Who Profit from the Silence
Who benefits when a virus is left unmonitored, unvaccinated, and unclassified? The same global health cartels that always do: the foundation-funded networks that manufacture both the crisis and the cure. No commercial vaccine exists for Shamonda, but the technology to create one has been ready for years. They are waiting—waiting for enough human cases to justify emergency approvals, mandatory jabs, and a new line of revenue. The patient’s death will be quietly attributed to “underlying illness,” but the autopsy data will be locked in a drawer. Here’s your breadcrumb: search the grant portfolios of the major health foundations for “midge-borne virus preparedness” between 2018 and 2022. You will find the names of the labs that were already gearing up for this moment. The case in Lyon is not a beginning. It is a checkpoint.
